Skip to main content

Schuyler Kevin

In the past year, 1 open-market purchase filing worth $10.2K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$10.2K
1 filing
Sold
–
0 filings
Net
+$10.2K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Schuyler Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

VEEE Twin Vee PowerCats, Co.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 22, 2022 (view filing)Dec 21-221 daySchuyler KevinDirectorPPurchase+1.36K$1.78+$2.43KNew position1.36K after2 lots
Mar 19, 2026 (view filing)5:01 PM ETMar 19Same daySchuyler KevinDirectorPPurchase+25.0K$0.4066+$10.2K+399.9%31.3K after

FRZA Forza X1, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 21, 2022 (view filing)Dec 201 daySchuyler KevinDirectorPPurchase+4.33K$1.20+$5.20KNew position4.33K after
Dec 22, 2022 (view filing)Dec 22Same daySchuyler KevinDirectorPPurchase+5.00K$1.14+$5.70K+115.4%9.33K after
Sep 18, 2024 (view filing)8:00 AM ETSep 171 daySchuyler KevinDirectorPPurchase+90.7K$0.30+$27.2K+971.6%100.0K after

ADIL Adial Pharmaceuticals, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 3, 2023 (view filing)Sep 294 daysSchuyler KevinDirectorPPurchase+700$2.74+$1.92KNew position700 after